Mesa Laboratories (NASDAQ:MLAB) CFO Sells $253,016.50 in Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB) CFO John Sakys sold 2,827 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $89.50, for a total transaction of $253,016.50. Following the transaction, the chief financial officer owned 19,785 shares of the company’s stock, valued at $1,770,757.50. This trade represents a 12.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John Sakys also recently made the following trade(s):

• On Tuesday, June 16th, John Sakys sold 1,223 shares of Mesa Laboratories stock. The shares were sold at an average price of $101.27, for a total value of $123,853.21.

Mesa Laboratories Trading Up 3.9%

Shares of MLAB stock opened at $98.15 on Friday. The firm has a market capitalization of $542.28 million, a P/E ratio of 81.79 and a beta of 0.94. Mesa Laboratories, Inc. has a twelve month low of $55.45 and a twelve month high of $113.99. The company has a quick ratio of 1.29, a current ratio of 1.72 and a debt-to-equity ratio of 0.78. The stock’s fifty day simple moving average is $101.79 and its 200 day simple moving average is $91.35.

Mesa Laboratories (NASDAQ:MLAB) last posted its earnings results on Wednesday, May 27th. The medical instruments supplier reported $1.53 EPS for the quarter, missing the consensus estimate of $1.78 by ($0.25). Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. The firm had revenue of $63.72 million during the quarter, compared to the consensus estimate of $65.21 million. During the same quarter in the prior year, the business posted ($1.31) earnings per share.

Mesa Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Friday, May 29th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, May 29th. This represents a $0.64 annualized dividend and a dividend yield of 0.7%. Mesa Laboratories’s dividend payout ratio is currently 53.33%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. grew its position in shares of Mesa Laboratories by 5,366.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Mesa Laboratories during the fourth quarter worth about $27,000. Kestra Advisory Services LLC bought a new position in shares of Mesa Laboratories during the fourth quarter worth about $55,000. BNP Paribas Financial Markets lifted its stake in shares of Mesa Laboratories by 115.3% in the second quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier’s stock worth $74,000 after acquiring an additional 421 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Mesa Laboratories by 432.9% in the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock worth $79,000 after acquiring an additional 684 shares during the period. 90.60% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, June 3rd. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $94.00.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.